NEW YORK (GenomeWeb) – The Alliance Global Group (AGBL) today announced an exclusive master distribution agreement for Fluxion Biosciences' IsoFlux and BioFlux systems in emerging markets in the Middle East, Asia, and Africa.

The IsoFlux Cell Separation System allows researchers to detect variants in circulating tumor cells by next-generation sequencing. The BioFlux System is for the introduction of flow conditions into research and drug discovery experiments to emulate the in vivo environment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.